Advertisement
Canada markets close in 6 hours 4 minutes
  • S&P/TSX

    21,839.28
    +130.84 (+0.60%)
     
  • S&P 500

    5,012.72
    +1.60 (+0.03%)
     
  • DOW

    37,954.10
    +178.72 (+0.47%)
     
  • CAD/USD

    0.7273
    +0.0010 (+0.14%)
     
  • CRUDE OIL

    82.74
    +0.01 (+0.01%)
     
  • Bitcoin CAD

    89,153.37
    +3,338.05 (+3.89%)
     
  • CMC Crypto 200

    1,331.43
    +18.81 (+1.45%)
     
  • GOLD FUTURES

    2,398.80
    +0.80 (+0.03%)
     
  • RUSSELL 2000

    1,944.46
    +1.50 (+0.08%)
     
  • 10-Yr Bond

    4.6100
    -0.0370 (-0.80%)
     
  • NASDAQ

    15,542.40
    -59.10 (-0.38%)
     
  • VOLATILITY

    18.47
    +0.47 (+2.61%)
     
  • FTSE

    7,847.68
    -29.37 (-0.37%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • CAD/EUR

    0.6816
    -0.0005 (-0.07%)
     

How Puma Biotechnology Is Positioned Financially before Q2 2018

How Puma Biotechnology Is Positioned Financially before Q2 2018

Puma Biotechnology (PBYI) generated revenues of $66.5 million in the first quarter, including revenues of $36 million and $30.5 million from product sales and licenses, respectively.